AZN

AstraZeneca PLC NYQ · AZN

$168.90 -0.39 (-0.23%)

Pullback · -1.77σ Grade C

+ Compare Open in Sniper

Price chart

Timeframe

Range

Loading…

Latest bar · AZN

Momentum reads · latest daily bar

Last

$168.90

-0.39 (-0.23%)

Mkt cap

$261.9B

Healthcare

RSI(14)

39.0

neutral

Stochastic %K

13.8

oversold

MFI(14)

29.9

neutral

ADX(14)

20.5

building

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

Quarter	Revenue	Net income	Op income	FCF	Net margin	Op margin
2026-03-31	$15.3B	$3.1B	$4.2B	$1.8B	20.1%	27.8%
2025-12-31	$15.5B	$2.3B	$3.0B	$1.1B	15.0%	19.2%
2025-09-30	$15.2B	$2.5B	$3.6B	$3.4B	16.7%	23.6%
2025-06-30	$14.5B	$2.5B	$3.5B	$1.5B	16.9%	24.3%
2025-03-31	$13.6B	$2.9B	$3.7B	$2.7B	21.5%	27.0%
2024-12-31	$nanB	$nanB	$nanB	$nanB	nan%	nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare AZN vs peers

Line AZN up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing AZN JNJ× TSLA× ABBV×

Sector peers + LLY + UNH + MRK + PFE + TMO

Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + AVGO

Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Verdict

Weighted score 0-100 across 4 tickers · best in green

AZN

score 65.9

5/5 inputs

Sentiment score of 88 with 26.93% analyst upside drives rank despite catastrophic momentum score of just 8.

value 88growth 79quality 63momentum 8sentiment 88

JNJ

score 65.0

5/5 inputs

Balanced profile with strongest momentum at 78 and quality at 75 offsets weak 41 growth score.

value 77growth 41quality 75momentum 78sentiment 56

TSLA

score 31.9

5/5 inputs

Perfect 100 growth score with 15.8% revenue growth cannot overcome catastrophic zero value score from 346 PE.

value 0growth 100quality 24momentum 9sentiment 10

ABBV

score 65.2

5/5 inputs

Dominant 0.42 PEG ratio powers 90 value score and 92 momentum score secures second rank overall.

value 90growth 32quality 49momentum 92sentiment 61

Metric	AZN AZN	JNJ Johnson & Johnson	TSLA Tesla, Inc.	ABBV AbbVie Inc.
Snapshot
Price	168.9	253.04	380.84	254.49
Day %↕	-0.23	1.23	-2.61	0.04
1M %↕	-5.49	7.59	-5.89	14.39
3M %↕	-15.75	7.89	-2.07	21.77
YTD %↕	-7.78	22.04	-13.06	10.98
Market cap	261943099392.0	609122123776.0	1430329884672.0	449631125504.0
ADV ($)	375460463.93203735	2085141651.2352905	18811567626.19034	1818746671.4276276
Beta	0.225	0.235	1.802	0.283
OdysseyHQ zone
Current zone	Pullback	Neutral	Pullback	Extended
Dist 21-EMA %	-5.17	0.93	-4.52	3.95
Dist ATR (σ)	-1.77	0.38	-1.07	1.46
OdysseyHQ grade	C	—	—	—
Confluence↕	2	1	2	2
Valuation
P/E (ttm)↕	25.513596	29.320972	346.21817	124.75001
P/E (fwd)↕	19.24646	19.727968	149.10927	15.63166
P/S↕	4.3340077	6.220038	14.613246	7.1575656
EV/EBITDA↕	14.383	18.429	126.389	17.155
P/B↕	5.527375	7.500815	17.392338	-67.55774
FCF yield↕	0.025	—	0.0037	0.0463
PEG↕	1.32	4.18	4.77	0.42
Growth
Revenue yoy↕	0.125	0.066	0.158	0.124
EPS yoy↕	0.053	-0.01	0.083	-0.462
FCF yoy↕	—	—	—	—
Revenue trend 8Q
Quality
Gross margin↕	0.81504995	0.68097	0.19065	0.72026
Operating margin↕	0.27943	0.28605	0.04203	0.32156
Net margin↕	0.17188999	0.21482	0.03946	0.05786
ROE↕	0.23482999	—	0.04901	—
ROA↕	0.08487	—	0.022330001	0.10032
Debt / Equity↕	0.72	0.68	0.19	—
Interest cov.↕	8.68	34.55	16.62	3.28
Technicals
RSI(14)	39.0	54.4	42.6	64.3
MACD signal	bear	neutral	bear	neutral
vs 50-DMA	-7.2	6.03	-7.07	11.56
vs 200-DMA	-8.56	13.51	-8.68	13.87
vs 52w high	-20.6	-6.08	-23.65	-2.73
HV-30	39.3	29.3	57.9	34.6
Sentiment
Analyst rec↕	1.6	1.91304	2.38298	1.74194
Target upside↕	26.93	6.68	11.65	4.75
Insider buy-sell 90d↕	1	13	-19	13
Risk
Short interest↕	0.1	1.23000005	2.3699999	1.38
Days to cover↕	0.74	2.96	1.66	2.52
Next earnings	2026-07-27	2026-10-13	2026-07-22	2026-07-31

AZN

$168.90

-0.23%

Snapshot

Price 168.9

Day % -0.23

1M % -5.49

3M % -15.75

YTD % -7.78

Market cap 261943099392.0

ADV ($) 375460463.93203735

Beta 0.225

OdysseyHQ zone

Current zone Pullback

Dist 21-EMA % -5.17

Dist ATR (σ) -1.77

OdysseyHQ grade C

Confluence 2

Valuation

P/E (ttm) 25.513596

P/E (fwd) 19.24646

P/S 4.3340077

EV/EBITDA 14.383

P/B 5.527375

FCF yield 0.025

PEG 1.32

Growth

Revenue yoy 0.125

EPS yoy 0.053

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.81504995

Operating margin 0.27943

Net margin 0.17188999

ROE 0.23482999

ROA 0.08487

Debt / Equity 0.72

Interest cov. 8.68

Technicals

RSI(14) 39.0

MACD signal bear

vs 50-DMA -7.2

vs 200-DMA -8.56

vs 52w high -20.6

HV-30 39.3

Sentiment

Analyst rec 1.6

Target upside 26.93

Insider buy-sell 90d 1

Risk

Short interest 0.1

Days to cover 0.74

Next earnings 2026-07-27

Full AZN dashboard →

JNJ

Johnson & Johnson

$253.04

+1.23%

Snapshot

Price 253.04

Day % 1.23

1M % 7.59

3M % 7.89

YTD % 22.04

Market cap 609122123776.0

ADV ($) 2085141651.2352905

Beta 0.235

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 0.93

Dist ATR (σ) 0.38

OdysseyHQ grade —

Confluence 1

Valuation

P/E (ttm) 29.320972

P/E (fwd) 19.727968

P/S 6.220038

EV/EBITDA 18.429

P/B 7.500815

FCF yield —

PEG 4.18

Growth

Revenue yoy 0.066

EPS yoy -0.01

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.68097

Operating margin 0.28605

Net margin 0.21482

ROE —

ROA —

Debt / Equity 0.68

Interest cov. 34.55

Technicals

RSI(14) 54.4

MACD signal neutral

vs 50-DMA 6.03

vs 200-DMA 13.51

vs 52w high -6.08

HV-30 29.3

Sentiment

Analyst rec 1.91304

Target upside 6.68

Insider buy-sell 90d 13

Risk

Short interest 1.23000005

Days to cover 2.96

Next earnings 2026-10-13

Full JNJ dashboard →

TSLA

Tesla, Inc.

$380.84

-2.61%

Snapshot

Price 380.84

Day % -2.61

1M % -5.89

3M % -2.07

YTD % -13.06

Market cap 1430329884672.0

ADV ($) 18811567626.19034

Beta 1.802

OdysseyHQ zone

Current zone Pullback

Dist 21-EMA % -4.52

Dist ATR (σ) -1.07

OdysseyHQ grade —

Confluence 2

Valuation

P/E (ttm) 346.21817

P/E (fwd) 149.10927

P/S 14.613246

EV/EBITDA 126.389

P/B 17.392338

FCF yield 0.0037

PEG 4.77

Growth

Revenue yoy 0.158

EPS yoy 0.083

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.19065

Operating margin 0.04203

Net margin 0.03946

ROE 0.04901

ROA 0.022330001

Debt / Equity 0.19

Interest cov. 16.62

Technicals

RSI(14) 42.6

MACD signal bear

vs 50-DMA -7.07

vs 200-DMA -8.68

vs 52w high -23.65

HV-30 57.9

Sentiment

Analyst rec 2.38298

Target upside 11.65

Insider buy-sell 90d -19

Risk

Short interest 2.3699999

Days to cover 1.66

Next earnings 2026-07-22

Full TSLA dashboard →

ABBV

AbbVie Inc.

$254.49

+0.04%

Snapshot

Price 254.49

Day % 0.04

1M % 14.39

3M % 21.77

YTD % 10.98

Market cap 449631125504.0

ADV ($) 1818746671.4276276

Beta 0.283

OdysseyHQ zone

Current zone Extended

Dist 21-EMA % 3.95

Dist ATR (σ) 1.46

OdysseyHQ grade —

Confluence 2

Valuation

P/E (ttm) 124.75001

P/E (fwd) 15.63166

P/S 7.1575656

EV/EBITDA 17.155

P/B -67.55774

FCF yield 0.0463

PEG 0.42

Growth

Revenue yoy 0.124

EPS yoy -0.462

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.72026

Operating margin 0.32156

Net margin 0.05786

ROE —

ROA 0.10032

Debt / Equity —

Interest cov. 3.28

Technicals

RSI(14) 64.3

MACD signal neutral

vs 50-DMA 11.56

vs 200-DMA 13.87

vs 52w high -2.73

HV-30 34.6

Sentiment

Analyst rec 1.74194

Target upside 4.75

Insider buy-sell 90d 13

Risk

Short interest 1.38

Days to cover 2.52

Next earnings 2026-07-31

Full ABBV dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

Date	EPS actual	EPS est	Surprise	Next-day
2026-04-29	1.29	1.27	+1.4%	+1.2%
2025-11-06	1.19	1.13	+4.9%	+1.0%
2025-07-29	0.79	0.88	-10.7%	+3.5%
2025-04-29	1.25	1.12	+11.6%	+0.1%
2025-02-06	1.05	1.04	+0.8%	-0.5%
2024-11-12	1.04	1.03	+1.1%	+0.1%
2024-07-25	0.99	0.99	-0.4%	-0.5%
2024-04-25	1.03	0.95	+8.4%	+0.2%
2024-02-08	0.73	0.76	-4.9%	-2.0%
2023-11-09	0.87	0.82	+5.3%	-1.4%
2023-07-28	1.08	0.97	+10.9%	+0.5%
2023-04-27	0.96	0.82	+17.6%	-0.8%
2023-02-09	0.69	0.68	+0.9%	+2.2%
2022-11-10	0.84	0.75	+11.9%	-3.6%
2022-07-29	0.86	1.04	-17.3%	-0.9%
2022-04-29	0.95	1.15	-17.6%	+0.1%
2022-02-10	0.84	0.99	-15.6%	-1.0%
2021-11-12	0.54	0.91	-40.9%	+1.7%
2021-07-29	0.45	0.69	-34.4%	-0.7%
2021-04-30	0.82	0.96	-15.3%	—

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅	Mkt cap ⇅	P/E ⇅	Fwd P/E ⇅	P/S ⇅	EV/EBITDA ⇅	P/B ⇅	Gross M ⇅	Rev gr ⇅	EPS gr ⇅	FCF yld ⇅
AZN ★	$262B	25.5	19.2	4.3	14.4	5.5	81.5%	12.5%	5.3%	2.50%
LLY	$1,051B	41.8	26.3	14.6	30.1	33.8	82.8%	55.5%	169.9%	0.87%
UNH	$387B	32.1	19.2	0.9	17.7	4.0	19.5%	0.4%	61.5%	5.88%
JNJ	$609B	29.3	19.7	6.2	18.4	7.5	68.1%	6.6%	-1.0%	—
MRK	$315B	36.0	13.2	4.8	12.1	6.9	76.7%	4.9%	—	4.46%
ABBV	$450B	124.8	15.6	7.2	17.2	-67.6	72.0%	12.4%	-46.2%	4.63%
PFE	$143B	19.1	8.8	2.3	7.6	1.6	74.8%	5.4%	-10.1%	8.67%
TMO	$198B	29.2	19.5	4.4	21.1	3.8	40.9%	6.2%	11.3%	2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 19.07%

Holder	Shares	% out
Investor AB	51,587,810	3.33%
Vanguard Capital Management LLC	45,040,142	2.90%
Capital International Investors	34,393,013	2.22%
FMR, LLC	29,601,724	1.91%
Capital World Investors	28,264,580	1.82%
Legal & General Group PLC	25,849,978	1.67%
Wellington Management Group, LLP	23,751,085	1.53%
Price (T.Rowe) Associates Inc	19,489,220	1.26%
Bank of America Corporation	19,058,327	1.23%
JPMORGAN CHASE & CO	18,590,922	1.20%

Insider activity · 90d

2 buys / 1 sells · ratio 2.0 · Finnhub

Sharma Mani BUY 19,265 @ $190.43
Sharma Mani BUY 19,263 @ $179.75
Sharma Mani SELL 19,262 @ $185.78

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low

$184.0

Mean

$214.39

High

$240.0

Analysts

Recommendation distribution · period 2026-07-01

Revision trend (2026-04-01 → 2026-07-01): net 27 → 27 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

Form	Filed	Description	Action
4	2026-07-08	OWNERSHIP DOCUMENT	view ·
4	2026-06-16	OWNERSHIP DOCUMENT	view ·
4	2026-05-22	OWNERSHIP DOCUMENT	view ·
4	2026-05-08	OWNERSHIP DOCUMENT	view ·
4	2021-03-16	4	view ·
4	2020-02-07	4	view ·
4	2019-10-09	FORM 4 SUBMISSION	view ·

About AZN

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and th…

Options picks · AZN

ITM + OTM ideas from the latest scan

Loading…

Congress trades · AZN

STOCK Act disclosures

Loading…

SEC filings & insiders · AZN

EDGAR · live

Loading…

Holders · AZN

Institutions & insider activity

Loading…

AstraZeneca PLC NYQ · AZN

Price chart

Latest bar · AZN

Financial overlay · last 12 quarters

Compare AZN vs peers

Earnings replay · last 20 reports

Peer comparison · Healthcare

Ownership

Top institutional holders

Insider activity · 90d

Analyst estimates

SEC filings

About AZN

Options picks · AZN

Congress trades · AZN

SEC filings & insiders · AZN

Holders · AZN

Filing summary